The DOI matches its Crossref record; 255 of the 257 references it cites were found in a registry or an index.
Muscle wasting in disease: molecular mechanisms and promising therapies
Abstract
Atrophy occurs in specific muscles with inactivity (for example, during plaster cast immobilization) or denervation (for example, in patients with spinal cord injuries). Muscle wasting occurs systemically in older people (a condition known as sarcopenia); as a physiological response to fasting or malnutrition; and in many diseases, including chronic obstructive pulmonary disorder, cancer-associated cachexia, diabetes, renal failure, cardiac failure, Cushing syndrome, sepsis, burns and trauma. The rapid loss of muscle mass and strength primarily results from excessive protein breakdown, which is often accompanied by reduced protein synthesis. This loss of muscle function can lead to reduced quality of life, increased morbidity and mortality. Exercise is the only accepted approach to prevent or slow atrophy. However, several promising therapeutic agents are in development, and major advances in our understanding of the cellular mechanisms that regulate the protein balance in muscle include the identification of several cytokines, particularly myostatin, and a common transcriptional programme that promotes muscle wasting. Here, we discuss these new insights and the rationally designed therapies that are emerging to combat muscle wasting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence also indicates that RT can effectively mitigate LM or skeletal muscle mass loss associated with dietary interventions (75) and in response to disease states (76).This occurs independently of reductions in body weight and fat mass.”
From Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition? (2024) · cites this paper as [75]
In the citing paper
“The muscle atrophy also occurs in cachexia, a comorbidity of abnormal conditions such as cancer, AIDS, congestive heart failure and chronic obstructive pulmonary disease, also occurs in sarcopenia, a decreases in muscle mass and strength associated with aging [61] .”
From Alternative Medicine: New Ways to Treat Diseases and Therapies (2021) · cites this paper as [61]
In the citing paper
“MuRF1 ubiquitinates several muscle structural proteins, including troponin I, myosin heavy chains, actin, myosin-binding protein C, and myosin light chains 1 and 242.”
From Mechanisms of muscle atrophy and hypertrophy: implications in health and disease (2021) · cites this paper as [42]
In the citing paper
“Because muscle loss requires the activation of transcription‐dependent programme controlled by the regulation of a subset of genes named atrophy‐related genes or atrogenes,36 we monitored several atrogenes mRNAs”
From Fibroblast growth factor 21 controls mitophagy and muscle mass (2019) · cites this paper as [36]
In the citing paper
“Skeletal muscle mass is controlled by a fine balance between protein synthesis and protein degradation processes triggered by changes in physical activity11,14,15, yet the intrinsic muscular signaling networks driving muscle mass loss particularly during the early phase of muscle disuse remain unclear.”
From Disuse-associated loss of the protease Lonp1 in muscle impairs mitochondrial function and causes reduced skeletal muscle mass and strength (2022) · cites this paper as [14]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Wenz, T., Rossi, S. G., Rotundo, R. L., Spiegelman, B. M., & Moraes, C. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911570106 · Cited by 600
RetractedLozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Self-citationTranscriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Jäger, S., Handschin, C., St.-Pierre, J., & Spiegelman, B. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705070104 · Cited by 2,491
Evans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450
Mammalian Sirtuins: Biological Insights and Disease Relevance
Haigis, M. C., & Sinclair, D. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092250 · Cited by 2,085
FoxO3 Controls Autophagy in Skeletal Muscle In Vivo
Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., Burden, S. J., Di Lisi, R., Sandri, C., Zhao, J., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.001 · Cited by 1,953
Self-citation
Research works printed but not linked: 1
- Arany, Z. et al. The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 5, 35–46 (2007). · DOI · Paper page
Cited by
Nrf2-Keap1 signaling in oxidative and reductive stress
Bellezza, I., Giambanco, I., Minelli, A., & Donato, R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.02.010 · Cited by 2,053
Mechanisms of muscle atrophy and hypertrophy: implications in health and disease
Sartori, R., Romanello, V., & Sandri, M. (2021) · Nature Communications · doi:10.1038/s41467-020-20123-1 · Cited by 940
Role of Inactivity in Chronic Diseases: Evolutionary Insight and Pathophysiological Mechanisms
Booth, F. W., Roberts, C. K., Thyfault, J. P., Ruegsegger, G. N., & Toedebusch, R. G. (2017) · Physiological Reviews · doi:10.1152/physrev.00019.2016 · Cited by 696
The extracellular matrix protein agrin promotes heart regeneration in mice
Bassat, E., Mutlak, Y. E., Genzelinakh, A., Shadrin, I. Y., Baruch Umansky, K., Yifa, O., Kain, D., Rajchman, D., Leach, J., Riabov Bassat, D., et al. (2017) · Nature · doi:10.1038/nature22978 · Cited by 642
Self-citationUnderstanding cachexia as a cancer metabolism syndrome
Porporato, P. E. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.3 · Cited by 562
Metadata
- Authors
- Cohen, S., Nathan, J. A., & Goldberg, A. L.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- University of Cambridge (GB)
- Harvard University (US)
- Corresponding author
- Cohen, Shenhav
- Goldberg, Alfred L.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2014-12-31
- Volume
- 14
- Issue
- 1
- Pages
- 58-74
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1998867833
- Cited by
- 1,089
- References
- 257
- Citations by year
- 2026: 75 · 2025: 92 · 2024: 92 · 2023: 111 · 2022: 110 · 2021: 111 · 2020: 117 · 2019: 88 · 2018: 91 · 2017: 86 · 2016: 79 · 2015: 36
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (100140, 102770, 102770/Z/13/Z)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR055255, R01AR055255)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- muscle atrophy, sarcopenia, cancer cachexia, sepsis, denervation, immobilization, protein synthesis, protein degradation, myostatin, cytokines, exercise therapy, therapeutic agents, chronic obstructive pulmonary disease, diabetes mellitus, renal failure, heart failure, Cushing's syndrome
- MeSH terms
- Animals, Humans, Muscular Atrophy, Myofibrils, Quality of Life, Signal Transduction, Sepsis, Wasting Syndrome, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Muscle wasting in disease: molecular mechanisms and promising therapies. https://app.cochat.ai/papers/10.1038/nrd4467
- The paper
- Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015). Muscle wasting in disease: molecular mechanisms and promising therapies. Nature Reviews Drug Discovery. https://doi.org/10.1038/nrd4467
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.